- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02545478
Biomarkers in Infection
Early Detection of Inflammatory Biomarkers in Infection
Przegląd badań
Status
Warunki
Szczegółowy opis
The body's immune system and a subsequent inflammatory response are triggered during infection. The detection of an activated immune system, and an indication of the degree of the host response, is helpful to the clinician both in assessing the severity of infection and in patient treatment and management. Currently, the white blood cell count and the differential are the most common laboratory parameters for measuring host response. The sedimentation rate and CRP are also used to detect inflammation. However, these tests are all imperfect predictors, and a test providing a better assessment of immune response would be helpful to the clinician in patient care. Additionally, understanding host response to infection may be helpful in understanding the biology and pathophysiology of sepsis. There are other biomarkers and inflammatory markers that may be found early in the initial presentation of infection such as cytokines (VEGF IL-1,IL-4,IL-6, IL-10, PAF, TNF, lectins iNoS,etc.) and clotting factors (protein C, d-dimer, complements involved in the clotting cascade, CRP, etc) that may provide a means of early detection of systemic inflammation, cell dysfunction, and related conditions. Early identification of patients at risk for systemic inflammatory syndromes, sepsis and septic shock may help direct patients to earlier antibiotic administration and early intervention with goal directed therapy. It may also serve as a tool for risk stratification when components such as age, comorbid illness and infection type are included.
The endothelium and endothelial cell markers are important in sepsis, yet a somewhat under-studied field of research. Additionally, the endothelium is a key regulator of the microcirculation, a place where oxygen diffusion occurs. One focus of this study is to measure endothelial markers (ie VEGF) and other cytokines with the goal of correlating these markers with severity of sepsis. Another focus is to study the response of various components in the blood, including the leukocytes, red cells, the endothelium, as well as cellular components such as the mitochondria. We will specifically look at alterations in thiamine, Vitamin D, CoQ10,l-carnitine and other nutrients as part of (and as related to) the body's response. Recently, a non-invasive method of assessing microvascular circulation by orthogonal polarization spectral (OPS) imagery has become available using a non-invasive technology known as orthogonal polarization spectroscopy. This technique enables direct visualization and quantification of microcirculatory blood flow, and represents an important surrogate outcome to which endothelial cell marker may be correlated. This will involve placing the microscopy probe gently against the sublingual mucosa and collecting a videotape of the circulation lasting about twenty seconds. This process involves minimal (or no) risk - it is akin to taking a temperature and uses no radiation. This videotape will be examined later by a novel software program that quantifies the circulation and used as an important surrogate outcome measure. Additionally, we are going to perform echocardiography to better understand the heart's response to sepsis, and correlated the molecular responses that we find with the changes in the responses by the heart.
This is a multicenter, observational pilot study which aims to evaluate how early biomarkers of infection an inflammation perform in identifying patients at risk for poor outcomes in sepsis and septic shock. The study will utilize a cohort of patients presenting to the ED with suspected infection as well as non-infected control population.
These patients will be compared with a non-infected population.
Enrolled subjects in the infected group will have blood samples and chart review obtained at enrollment, 24, 48 and 72 hours. For the control group, only a single blood draw will be collected at enrollment.
Enrolled subjects will also undergo physiologic assessments using echocardiography, Microscan, Non-invasive cardiac output monitor (NICOM), extremity temperature as well as End-Tidal C02 measurements if a trained researcher is present.
Typ studiów
Zapisy (Oczekiwany)
Kontakty i lokalizacje
Kontakt w sprawie studiów
- Nazwa: Nathan Shapiro, MD MPH
- Numer telefonu: 617-754-2343
- E-mail: nshapiro@bidmc.harvard.edu
Kopia zapasowa kontaktu do badania
- Nazwa: Sharon R Hayes, RN
- Numer telefonu: 617-754-2334
- E-mail: srhayes@bidmc.harvard.edu
Lokalizacje studiów
-
-
-
Aarhus, Dania
- Jeszcze nie rekrutacja
- Aarhus Universitetshospital
-
Kontakt:
- Hans Kirkegaard
- E-mail: Hans Kirkegaard <hanskirkegaard@dadlnet.dk>
-
Główny śledczy:
- Hans Kirkegaard, MD
-
-
-
-
Massachusetts
-
Boston, Massachusetts, Stany Zjednoczone, 02215
- Rekrutacyjny
- Beth Israel Deaconess Medical Center
-
Kontakt:
- Nathan Shapiro, MD MPH
- Numer telefonu: 617-754-2343
- E-mail: nshapiro@bidmc.harvard.edu
-
Boston, Massachusetts, Stany Zjednoczone, 02114
- Aktywny, nie rekrutujący
- Massachusetts General Hospital
-
Boston, Massachusetts, Stany Zjednoczone, 02215
- Aktywny, nie rekrutujący
- Brigham and Women's Hospital
-
Worcester, Massachusetts, Stany Zjednoczone, 01608
- Rekrutacyjny
- St. Vincent's Hospital
-
Kontakt:
- David Miru, RN
- Numer telefonu: 508-363-5286
- E-mail: dmiru@bidmc.harvard.edu
-
Kontakt:
- Pamel Sigel, RN
- Numer telefonu: 508-363-7018
- E-mail: PAMELA.SIGEL@stvincenthospital.com
-
Główny śledczy:
- Nathan Shapiro, MD MPH
-
-
New York
-
Brooklyn, New York, Stany Zjednoczone, 11215
- Rekrutacyjny
- New York Methodist Hospital
-
Kontakt:
- Robert Birkhahn, MD
-
Główny śledczy:
- Rorber Birkhahn, MD
-
-
Tennessee
-
Nashville, Tennessee, Stany Zjednoczone, 37232
- Rekrutacyjny
- Vanderbiltt University
-
Kontakt:
- Wesley Self, MD
- Numer telefonu: 615-936-0253
- E-mail: wesley.self@vanderbilt.edu
-
Główny śledczy:
- Wesley Self, MD
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Metoda próbkowania
Badana populacja
Opis
Inclusion Criteria for Infected subjects:
- Age 18 years of age or older
- Confirmed or suspected infection
Inclusion Criteria for Control Subjects:
- Age 18 years of age or older
- A non-infectious clinical presentation to include
- Normal white blood cell count ( > 4,000 and/or < 12,000)
- Normothermia ( > 96.5 and/or less 100.4)
- Absence of the following clinical complaints: productive cough, fever, pyuria, rash
- No evidence of acute coronary syndrome
Exclusion Criteria for Control Subjects:
- Suspected infection
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
Kohorty i interwencje
Grupa / Kohorta |
---|
Infected Group
subjects with suspected infection
|
Non-infected group
subjects without any infection
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
28 day in-hospital mortality
Ramy czasowe: within 28 days after inclusion
|
participants will be followed up for 28 days
|
within 28 days after inclusion
|
Miary wyników drugorzędnych
Miara wyniku |
Ramy czasowe |
---|---|
Organ Dysfunction assessed by Sepsis-related Organ Failure Assessment (SOFA) Score
Ramy czasowe: within 24 hours
|
within 24 hours
|
Współpracownicy i badacze
Śledczy
- Główny śledczy: Nathan Shapiro, MD MPH, Beth Israel Deaconess Medical Center
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Oczekiwany)
Ukończenie studiów (Oczekiwany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 2005P000116
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Posocznica
-
Drugs for Neglected DiseasesUniversiteit Antwerpen; PENTA Foundation; St George's, University of LondonZakończonySEPSIS noworodkówBangladesz, Uganda, Tajlandia, Afryka Południowa, Włochy, Grecja, Indie, Brazylia, Chiny, Kenia, Wietnam
-
Assiut UniversityNieznany
-
Assiut UniversityNieznany
-
Ahmed Mahmoud Ali Ali YoussefZakończony
-
Assiut UniversityNieznany
-
London School of Hygiene and Tropical MedicineZakończonySEPSIS noworodkówBurkina Faso, Gambia
-
Stephanie BjerrumRigshospitalet, Denmark; University of Copenhagen; University of Ghana; Korle-Bu...Zakończony
-
Drugs for Neglected DiseasesUniversity of Oxford; KEMRI-Wellcome Trust Collaborative Research ProgramZakończonySEPSIS noworodkówKenia
-
Gehad AbdelnaserAssiut UniversityNieznany
-
Franciscus GasthuisErasmus Medical CenterZakończonyZakażenie noworodków | SEPSIS noworodkówHolandia